Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Na Shen
Observed names:
N Shen,
Shen Na
Institutions:
Chinese Academy of Sciences,
Changchun Institute of Applied Chemistry
Observed institutions:
National Institutes of Health,
University of Minnesota,
Jilin University,
Chinese Academy of Sciences,
Changchun Institute of Applied Chemistry,
National Cancer Institute,
Center for Cancer Research,
The Ohio State University
show all 8
ORCID:
0000-0003-1557-1060
Observed ORCID:
0000-0003-1557-1060
OpenAlex ID:
A5012521983
Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia‐Activated Prodrug Tirapazamine Therapy for Metastatic Tumors
2019
·
Shengcai Yang
, Zhaohui Tang
, et al.
·
Advanced Materials
·
210
CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF Signaling
2006
·
Xiaolin Wan
, Na Shen
, et al.
·
Neoplasia
·
148
PDF
Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin Prodrug
2019
·
Jian Jiang
, Na Shen
, et al.
·
Advanced Materials
·
114
Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy
2018
·
Rong Deng
, Na Shen
, et al.
·
Biomaterials
·
106
Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells
2016
·
F Yan
, N Shen
, et al.
·
Leukemia
·
102
Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation
2014
·
F Yan
, N Shen
, et al.
·
Cell Death and Disease
·
94
PDF
AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation
2015
·
X N Gao
, F Yan
, et al.
·
Leukemia
·
90
Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment
2019
·
Na Shen
, Jing Wu
, et al.
·
Nano Letters
·
85
Hypoxia-sensitive supramolecular nanogels for the cytosolic delivery of ribonuclease A as a breast cancer therapeutic
2020
·
Xinghui Si
, Sheng Ma
, et al.
·
Journal of Controlled Release
·
76
PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly( l ‐Glutamic Acid)‐Combretastatin A4 Conjugate in Metastatic Breast Cancer
2019
·
Hanjiao Qin
, Haiyang Yu
, et al.
·
Advanced Science
·
72
PDF
Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells
2017
·
Jiuxia Pang
, Na Shen
, et al.
·
Oncotarget
·
64
PDF
Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect
2022
·
Zhilin Liu
, Yu Zhang
, et al.
·
Advanced Drug Delivery Reviews
·
63
Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance
2016
·
Wantong Song
, Zhaohui Tang
, et al.
·
Journal of Controlled Release
·
62
An eximious and affordable GSH stimulus-responsive poly(α-lipoic acid) nanocarrier bonding combretastatin A4 for tumor therapy
2019
·
Zhilin Liu
, Na Shen
, et al.
·
Biomaterials Science
·
61
A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target
2017
·
F Yan
, N Shen
, et al.
·
Leukemia
·
55
A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis
2014
·
Na Shen
, Fei Yan
, et al.
·
Oncotarget
·
55
PDF
Cisplatin nanoparticles possess stronger anti-tumor synergy with PD1/PD-L1 inhibitors than the parental drug
2021
·
Na Shen
, Chenguang Yang
, et al.
·
Acta Biomaterialia
·
49
Enhanced anti-PD-1 therapy in hepatocellular carcinoma by tumor vascular disruption and normalization dependent on combretastatin A4 nanoparticles and DC101
2021
·
Xin Bao
, Na Shen
, et al.
·
Theranostics
·
47
Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia
2017
·
Na Shen
, Fei Yan
, et al.
·
Clinical Cancer Research
·
41
Self‐Amplifying Nanotherapeutic Drugs Homing to Tumors in a Manner of Chain Reaction
2020
·
Yue Wang
, Na Shen
, et al.
·
Advanced Materials
·
40
A novel nanozyme based on selenopeptide-modified gold nanoparticles with a tunable glutathione peroxidase activity
2020
·
Dechen Zhang
, Na Shen
, et al.
·
RSC Advances
·
37
PDF
Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia
2019
·
Liping Dou
, Fei Yan
, et al.
·
Nature Communications
·
33
PDF
Cisplatin Nanoparticles Promote Intratumoral CD8+ T Cell Priming via Antigen Presentation and T Cell Receptor Crosstalk
2022
·
Haochen Yao
, Na Shen
, et al.
·
Nano Letters
·
32
The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2′-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells
2015
·
Fei Yan
, Na Shen
, et al.
·
Journal of Biological Chemistry
·
32
Dihydroartemisinin increases gemcitabine therapeutic efficacy in ovarian cancer by inducing reactive oxygen species
2018
·
Shengcai Yang
, Dawei Zhang
, et al.
·
Journal of Cellular Biochemistry
·
30
Show more works
View as search
Works count:
69
Citation count:
2,303
H-index:
27
I10-index:
47
Year
Topic
Type